Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA (Y.H., J.W.H., A.P.R., C.K.).
School of Public Health, University of Wisconsin-Milwaukee (R.M., P.L.A.).
Stroke. 2022 Mar;53(3):875-885. doi: 10.1161/STROKEAHA.120.031792. Epub 2021 Nov 3.
Stroke is the leading cause of death and long-term disability worldwide. Previous genome-wide association studies identified 51 loci associated with stroke (mostly ischemic) and its subtypes among predominantly European populations. Using whole-genome sequencing in ancestrally diverse populations from the Trans-Omics for Precision Medicine (TOPMed) Program, we aimed to identify novel variants, especially low-frequency or ancestry-specific variants, associated with all stroke, ischemic stroke and its subtypes (large artery, cardioembolic, and small vessel), and hemorrhagic stroke and its subtypes (intracerebral and subarachnoid).
Whole-genome sequencing data were available for 6833 stroke cases and 27 116 controls, including 22 315 European, 7877 Black, 2616 Hispanic/Latino, 850 Asian, 54 Native American, and 237 other ancestry participants. In TOPMed, we performed single variant association analysis examining 40 million common variants and aggregated association analysis focusing on rare variants. We also combined TOPMed European populations with over 28 000 additional European participants from the UK BioBank genome-wide array data through meta-analysis.
In the single variant association analysis in TOPMed, we identified one novel locus for large artery at whole-genome-wide significance (<5.00×10) and 4 novel loci at genome-wide significance (<5.00×10), all of which need confirmation in independent studies. Lead variants in all 5 loci are low-frequency but are more common in non-European populations. An aggregation of synonymous rare variants within the gene demonstrated suggestive evidence of association for hemorrhagic stroke (<3.11×10). By meta-analyzing European ancestry samples in TOPMed and UK BioBank, we replicated several previously reported stroke loci including , , , and .
We represent the first association analysis for stroke and its subtypes using whole-genome sequencing data from ancestrally diverse populations. While our findings suggest the potential benefits of combining whole-genome sequencing data with populations of diverse genetic backgrounds to identify possible low-frequency or ancestry-specific variants, they also highlight the need to increase genome coverage and sample sizes.
卒中是全球范围内导致死亡和长期残疾的主要原因。先前的全基因组关联研究在主要为欧洲人群中鉴定出与卒中(主要是缺血性卒中)及其亚型相关的 51 个位点。利用来自跨组学精准医学(TOPMed)计划的具有多种祖先背景的人群进行全基因组测序,我们旨在鉴定与所有卒中、缺血性卒中和其亚型(大动脉、心源性栓塞和小血管)以及出血性卒中和其亚型(脑内和蛛网膜下腔)相关的新变体,特别是低频或特定于祖先的变体。
6833 例卒中病例和 27116 例对照的全基因组测序数据可用于研究,包括 22315 例欧洲人、7877 例黑人、2616 例西班牙裔/拉丁裔、850 例亚洲人、54 例美洲原住民和 237 例其他祖先人群。在 TOPMed 中,我们进行了单变体关联分析,检测了 4000 万个常见变体,并进行了罕见变体的聚集关联分析。我们还通过荟萃分析将 TOPMed 的欧洲人群与 UK BioBank 全基因组阵列数据中超过 28000 名额外的欧洲参与者进行了合并。
在 TOPMed 的单变体关联分析中,我们在全基因组范围内鉴定出一个与大动脉相关的新位点(全基因组范围内显著水平<5.00×10)和 4 个新的与全基因组范围内显著水平(<5.00×10)相关的新位点,所有这些都需要在独立研究中进行确认。所有 5 个位点的先导变体均为低频,但在非欧洲人群中更为常见。基因内同义稀有变异的聚集显示出与出血性卒中(<3.11×10)有提示性关联的证据。通过荟萃分析 TOPMed 和 UK BioBank 中的欧洲血统样本,我们复制了几个先前报道的卒中相关位点,包括、、、和。
我们代表了首次使用具有多种祖先背景的人群进行全基因组测序数据进行卒中及其亚型的关联分析。虽然我们的研究结果表明,将全基因组测序数据与具有多种遗传背景的人群相结合以鉴定可能的低频或特定于祖先的变体具有潜在的益处,但它们也突出表明需要增加基因组覆盖度和样本量。